Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 41-44 , April 2010

Particle therapy at the Heidelberg Ion Therapy Center (HIT) – Integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany

  • Stephanie E. Combs

      Affiliations

    • Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
    • ,
  • Oliver Jäkel

      Affiliations

    • Heidelberg Ion Therapy Center (HIT), Heidelberg, Germany
    • Department of Medical Physics, German Cancer Research Center (dkfz), Heidelberg, Germany
    • ,
  • Thomas Haberer

      Affiliations

    • Heidelberg Ion Therapy Center (HIT), Heidelberg, Germany
    • ,
  • Jürgen Debus

      Affiliations

    • Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany

Received 6 January 2010 ,Revised 13 February 2010 ,Accepted 17 February 2010.

Reference 

  1. Haberer T, Becher W, Schardt D, Kraft G. Magnetic scanning system for heavy ion therapy. Nucl Instrum Methods Phys Res. 1993;A330:296–305
  2. Weyrather WK, Kraft G. RBE of carbon ions: experimental data and the strategy of RBE calculation for treatment planning. Radiother Oncol. 2004;73(Suppl 2):S161–S169
  3. Jakel O, Kramer M, Schulz-Ertner D, Heeg P, Karger CP, Didinger B, et al. Treatment planning for carbon ion radiotherapy in Germany: review of clinical trials and treatment planning studies. Radiother Oncol. 2004;73(Suppl 2):S86–S91
  4. Schulz-Ertner D, Karger CP, Feuerhake A, Nikoghosyan A, Combs SE, Jakel O, et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys. 2007;68:449–457
  5. Schulz-Ertner D, Nikoghosyan A, Hof H, Didinger B, Combs SE, Jakel O, et al. Carbon ion radiotherapy of skull base chondrosarcomas. Int J Radiat Oncol Biol Phys. 2007;67:171–177
  6. Schulz-Ertner D, Nikoghosyan A, Didinger B, Munter M, Jakel O, Karger CP, et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer. 2005;104:338–344
  7. Haberer T, Debus J, Eickhoff H, Jakel O, Schulz-Ertner D, Weber U. The Heidelberg Ion Therapy Center. Radiother Oncol. 2004;73(Suppl 2):S186–S190
  8. Kramer M, Weyrather WK, Scholz M. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning. Technol Cancer Res Treat. 2003;2:427–436
  9. Kramer M, Scholz M. Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose. Phys Med Biol. 2000;45:3319–3330
  10. Kramer M, Jakel O, Haberer T, Kraft G, Schardt D, Weber U. Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. Phys Med Biol. 2000;45:3299–3317
  11. Elsasser T, Kramer M, Scholz M. Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo. Int J Radiat Oncol Biol Phys. 2008;71:866–872
  12. Enghardt W, Debus J, Haberer T, Hasch BG, Hinz R, Jakel O, et al. The application of PET to quality assurance of heavy-ion tumor therapy. Strahlenther Onkol. 1999;175(Suppl 2):33–36
  13. Parodi K, Enghardt W, Haberer T. In-beam PET measurements of beta+ radioactivity induced by proton beams. Phys Med Biol. 2002;47:21–36
  14. Fiedler F, Priegnitz M, Julich R, Pawelke J, Crespo P, Parodi K, et al. In-beam PET measurements of biological half-lives of 12C irradiation induced beta+-activity. Acta Oncol. 2008;47:1077–1086
  15. Parodi K, Enghardt W. Potential application of PET in quality assurance of proton therapy. Phys Med Biol. 2000;45:N151–N156
  16. Parodi K, Saito N, Chaudhri N, Richter C, Durante M, Enghardt W, et al. 4D in-beam positron emission tomography for verification of motion-compensated ion beam therapy. Med Phys. 2009;36:4230–4243
  17. Enghardt W, Parodi K, Crespo P, Fiedler F, Pawelke J, Ponisch F. Dose quantification from in-beam positron emission tomography. Radiother Oncol. 2004;73(Suppl. 2):S96–S98
  18. Bert C, Saito N, Schmidt A, Chaudhri N, Schardt D, Rietzel E. Target motion tracking with a scanned particle beam. Med Phys. 2007;34:4768–4771
  19. Bert C, Rietzel E. 4D treatment planning for scanned ion beams. Radiat Oncol. 2007;2:24
  20. Grozinger SO, Bert C, Haberer T, Kraft G, Rietzel E. Motion compensation with a scanned ion beam: a technical feasibility study. Radiat Oncol. 2008;3:34
  21. Bert C, Grozinger SO, Rietzel E. Quantification of interplay effects of scanned particle beams and moving targets. Phys Med Biol. 2008;53:2253–2265
  22. Bert C, Gemmel A, Saito N, Rietzel E. Gated irradiation with scanned particle beams. Int J Radiat Oncol Biol Phys. 2009;73:1270–1275
  23. Koto M, Miyamoto T, Yamamoto N, Nishimura H, Yamada S, Tsujii H. Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol. 2004;71:147–156
  24. Ishikawa H, Tsuji H, Kamada T, Yanagi T, Mizoe JE, Kanai T, et al. Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study. Radiother Oncol. 2006;81:57–64
  25. Tsujii H, Mizoe JE, Kamada T, Baba M, Kato S, Kato H, et al. Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol. 2004;73(Suppl 2):S41–S49
  26. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol. 2007;25:953–964
  27. Lodge M, Pijls-Johannesma M, Stirk L, Munro AJ, De Ruysscher D, Jefferson T. A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiother Oncol. 2007;83:110–122
  28. Combs SE, Nikoghosyan A, Jaekel O, Karger CP, Haberer T, Munter MW, et al. Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base. Cancer. 2009;115:1348–1355
  29. Schulz-Ertner D, Nikoghosyan A, Didinger B, Debus J. Carbon ion radiation therapy for chordomas and low grade chondrosarcomas--current status of the clinical trials at GSI. Radiother Oncol. 2004;73(Suppl 2):S53–S56
  30. Terahara A, Niemierko A, Goitein M, Finkelstein D, Hug E, Liebsch N, et al. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys. 1999;45:351–358
  31. Ares C, Hug EB, Lomax AJ, Bolsi A, Timmermann B, Rutz HP, et al. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys. 2009;75:1111–1118
  32. Combs SE, Bohl J, Elsasser T, Weber KJ, Schulz-Ertner D, Debus J, et al. Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines. Int J Radiat Biol. 2009;85:126–137
  33. Combs SE, Hartmann C, Nikoghosyan A, Jakel O, Karger C, Münter MW, et al. Carbon ion radiation therapy for high risk meningiomas. Radiother Oncol. 2010;95:54–59
  34. Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, et al. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol. 2009;27:5874–5880
  35. Dawson LA, Ten Haken RK. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol. 2005;15:279–283
  36. Kato H, Tsujii H, Miyamoto T, Mizoe JE, Kamada T, Tsuji H, et al. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys. 2004;59:1468–1476

PII: S0167-8140(10)00109-X

doi: 10.1016/j.radonc.2010.02.016

Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 41-44 , April 2010

Article Tools

* Image Usage & Resolution